HB2020 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

HB2020 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity. · Informed CitizenryHB2020 amends the Controlled Substance, Drug, Device and Cosmetic Act to provide for drug overdose response immunity. The bill specifies that individuals who transport or report a drug overdose eve…Open in Informed Citizenry